###begin article-title 0
###xml 63 71 <span type="species:ncbi:9606">Children</span>
Association of Interleukin-10 A-592C Polymorphism in Taiwanese Children with Kawasaki Disease
###end article-title 0
###begin p 1
###xml 340 350 340 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-592 IL-10</italic>
###xml 550 555 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 688 693 688 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 720 721 720 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 866 867 866 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 929 934 929 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 1027 1032 1027 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 1134 1139 1134 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 1223 1228 1223 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
###xml 429 437 <span type="species:ncbi:9606">patients</span>
###xml 475 483 <span type="species:ncbi:9606">patients</span>
###xml 808 816 <span type="species:ncbi:9606">patients</span>
###xml 1168 1176 <span type="species:ncbi:9606">patients</span>
###xml 1296 1304 <span type="species:ncbi:9606">children</span>
Elevated serum levels of interleukin-10 (IL-10) have been reported in patients with Kawasaki disease (KD). IL-10 reduces the inflammatory actions of macrophages and T cells and it may play a significant role in the regulation of inflammatory vascular damage associated with systemic vasculitis. The aim of this study was to examine whether -592 IL-10 promoter polymorphism is a susceptibility or severity marker of KD in Chinese patients in Taiwan. The study included 105 KD patients and 100 normal controls. Genotype and allelic frequencies for the IL-10 gene polymorphism in both groups were compared. There were no significant between-group differences in the genotype distribution of IL-10 A-592C gene polymorphism (P=0.08). However, the frequency of the -592*A allele was significantly increased in the patients with KD compared with controls (71.9% vs. 61.0%, P=0.019). The odds ratio for developing KD in individuals with IL-10-592*A allele was 1.64 (95% confidence interval, 1.06-2.52) compared to individuals with the IL-10-592*C allele. No significant difference was observed in the genotype and allelic frequencies for the IL-10 A-592C polymorphism between patients with and without coronary artery lesions. The IL-10-592*A allele may be involved in the development of KD in Taiwanese children.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 576 577 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 578 579 567 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 752 753 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 852 853 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 855 856 844 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 858 859 847 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1048 1049 1037 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1357 1358 1346 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1451 1453 1436 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1455 1457 1440 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1609 1611 1594 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1720 1722 1701 1703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1724 1726 1705 1707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1882 1884 1863 1865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 2113 2115 2094 2096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 81 88 <span type="species:ncbi:9606">infants</span>
###xml 99 107 <span type="species:ncbi:9606">children</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
###xml 237 245 <span type="species:ncbi:9606">children</span>
Kawasaki disease (KD) is an acute systemic vasculitis that predominantly affects infants and young children. Coronary artery lesions (CALs) develop in 20-25% of the patients, which makes KD the leading cause of acquired heart disease in children. The cause of this disease is unknown but generally believed to be an infectious agent (1). Many reports have noted an abnormal immune response in the acute phase of this disease and increase in serum cytokines, such as interleukin (IL)-1beta, IL-2, IL-4, IL-6, IL-8, interferon (INF)-gamma, and tumor necrosis factor (TNF)-alpha(2-5). These cytokines may mediate endothelial damage and lead to coronary artery disease while also producing the systemic signs of inflammation that characterize the disease (6). Previous reports have shown blood IL-10 levels were also elevated during the acute phase of KD (5, 7, 8). The elevated IL-10 levels decreased immediately after intravenous immune globulin (IVIG) administration, and the decrease was coincident with rapid improvement in inflammatory symptoms (8). However, the significance of increased IL-10 levels observed in KD is not fully understood. IL-10 is a major immunoregulatory cytokine and has a number of immunomodulating effects on the immune system. It is produced by many cell types, including T lymphocytes, B lymphocytes, monocytes, and macrophages (9). IL-10 suppresses type 1 T helper lymphocytes by decreasing IL-2 and INF-gamma production (10, 11). It also inhibits certain functions of activated macrophages by downregulating the expression of MHC class II antigens, and co-stimulatory molecules (12), and by inhibiting production of proinflammatory cytokines such as TNF-alpha, IL-1, IL-6, IL-8, and IL-12 (10, 13). Contrary to its T cell and macrophage inhibitory actions, IL-10 enhances B cell survival, proliferation, differentiation, and immunoglobulin production (14). Levels of IL-10 production are critical in immune regulation and control the balance between inflammatory and humoral responses. Various studies have confirmed the association of IL-10 with autoimmune and infectious diseases (15).
###end p 3
###begin p 4
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 487 492 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 303 309 <span type="species:ncbi:9606">humans</span>
The human IL-10 gene is located on chromosome 1 and has been mapped to the junction between 1q31 and 1q32 (16). The capacity for IL-10 production is correlated with the genetic composition of the IL-10 locus. Genetic factors account for approximately 75% of the variation in IL-10 secretion capacity in humans, and these genetic differences contribute to disease susceptibility (17). The variation of IL-10 expression is thought to be at the transcriptional level since mutations in the IL-10 gene promoter sequence may alter specific transcriptional activation and cytokine production (18).
###end p 4
###begin p 5
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
This study hypothesized that the IL-10 gene polymorphisms have a measurable influence on KD susceptibility and contribute to or reduce the occurrence of coronary artery lesions. To test this hypothesis, inheritance of the IL-10 promoter polymorphism at position -592 in patients with KD, as well as the association of the polymorphism with clinical complications of CALs, were examined.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
Subjects
###end title 7
###begin p 8
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 263 270 263 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 12 20 <span type="species:ncbi:9606">patients</span>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
###xml 312 320 <span type="species:ncbi:9606">patients</span>
###xml 763 771 <span type="species:ncbi:9606">children</span>
###xml 808 816 <span type="species:ncbi:9606">children</span>
###xml 1013 1021 <span type="species:ncbi:9606">children</span>
###xml 1173 1180 <span type="species:ncbi:9606">patient</span>
###xml 1233 1240 <span type="species:ncbi:9606">patient</span>
We enrolled patients with KD from the Department of Pediatrics at the China Medical University Hospital, Taichung, Taiwan. The study group included 105 patients, all of whom met the criteria proposed by the Japanese Kawasaki Disease Research Committee (19). (See Table 1 for the numbers of subject studied.) All patients were treated with IVIG (2 g/kg infused over 8-12 hr) and oral aspirin (80-100 mg/kg/day). Echocardiographs were obtained by the pediatric cardiologist before or within 2 weeks of IVIG administration. Coronary artery lesions were diagnosed from the echocardiograms using the criteria proposed by the Japanese Kawasaki Disease Research Committee (19): coronary arteries were classified as abnormal if the internal lumen diameter was >/=3 mm in children younger than 5 yr old or >/=4 mm in children older than 5 yr old, if the internal diameter of a segment measured >/=1.5 times that of an adjacent segment, or if the coronary lumen was clearly irregular. We also studied 100 unrelated healthy children (62 males and 38 females, 0.4-7.0 yr old, mean age=3.2 yr) who served as the control group. All blood samples were drawn before IVIG therapy in the KD patient group. Control samples were tested in parallel with patient samples. The ethics committee of the China Medical University Hospital Institutional Review Board approved the study, and written informed consent was obtained from the parents of all subjects.
###end p 8
###begin title 9
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
Analysis of IL-10 A-592C polymorphism
###end title 9
###begin p 10
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 603 604 595 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 624 627 616 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 1039 1042 1031 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 1235 1240 1227 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 1256 1259 1248 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
The genomic DNA was prepared from peripheral blood using a genomic DNA isolation reagent kit (Genomaker, Taipei, Taiwan). The IL-10 A-592C genotype was determined using a polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) assay. The primers were forward 5'-CCTAGGTCACAGTGACGTGG-3' and reverse 5'-GGTGAGCACTACCTGACTAGC-3'. This generated a PCR product of 412 bp. PCR amplification was done in a 50-microL reaction volume containing 100 ng of genomic DNA, 0.5 microM of each primer, 0.2 mM/L deoxynucleotide triphosphates, 10 mM/L Tris-HCl (pH 8.3), 50 mM/L KCl, 1.5 mM/L MgCl2, and 1.25 units of Taq polymerase (Perkin Elmer, Foster City, CA, U.S.A.). The PCR amplification was performed in a programmable thermal cycler (Gene Amp PCR System 2400; Perkin-Elmer). PCR cycle conditions consisted of an initial denaturation step at 95℃ for 5 min followed by 35 cycles of 1 min at 94℃, 1 min at 60℃, 1 min at 72℃, and a final extension at 72℃ for 6 min. The PCR products were digested with restriction endonuclease RasI (New England Biolabs, Beverly, MA, U.S.A.) and the digested DNA fragments were separated by 3% agarose gel electrophoresis and identified by ethidium bromide staining. In the presence of the IL-10 -592*A allele, RasI cut the 412 bp PCR product into two fragments of 236 and 176 bp, respectively.
###end p 10
###begin title 11
Statistical analysis
###end title 11
###begin p 12
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 332 333 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 168 176 <span type="species:ncbi:9606">patients</span>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
The SAS Version 8.2 (SAS Institute Inc., NC, U.S.A.) with chi-square test was used to compare the genotype and the allelic frequency distribution of the IL-10 gene for patients with KD and control subjects. A chi-square test was also used to compare differences between patients with and without coronary artery lesions. A value of P<0.05 indicated a significant difference between the tested populations. Associations between variables in cases and control subjects were determined using the odds ratio and 95% confidence interval.
###end p 12
###begin title 13
RESULTS
###end title 13
###begin title 14
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Characteristics of the study patients
###end title 14
###begin p 15
###xml 64 71 64 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 251 259 <span type="species:ncbi:9606">patients</span>
###xml 335 343 <span type="species:ncbi:9606">patients</span>
The characteristics of the 105 KD patients studied are shown in Table 1. The sex distribution of the total KD patients was a male/female ratio of 1.4:1, which is comparable to the previous reports of KD male/female ratios ranging from 1.5 to 1.7:1.31 patients (30%) were identified as having coronary artery lesions. Parents of all KD patients enrolled in the study on a voluntary basis; therefore, the study population is not representative of the true incidence of either KD or coronary artery lesions in Taiwan.
###end p 15
###begin title 16
Allele and genotype frequencies of IL-10 A-592C promoter polymorphisms
###end title 16
###begin p 17
###xml 74 81 74 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 357 362 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 442 443 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 588 589 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 665 670 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 763 768 763 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 803 808 803 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 1016 1023 1016 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
###xml 432 440 <span type="species:ncbi:9606">patients</span>
###xml 530 538 <span type="species:ncbi:9606">patients</span>
###xml 965 973 <span type="species:ncbi:9606">patients</span>
The frequencies of the genotype in the KD and control groups are shown in Table 2. Among the 105 KD patients, 56 (53.3%) had IL-10 genotype AA, 39 (37.1%) had AC, and 10 (9.6%) had CC. Among the 100 control subjects, 40 (40.0%) had genotype AA, 42 (42.0%) had AC, and 18 (18.0%) had CC. There were no significant differences in the genotype distribution of IL-10 A-592C gene polymorphism between the healthy control subjects and KD patients (P=0.08). However, the frequency of the -592*A allele was significantly increased in the patients with KD compared with controls (71.9% vs. 61.0%, P=0.019). The odds ratio for developing Kawasaki disease in individuals with IL-10-592*A allele was 1.64 (95% confidence interval, 1.06-2.52) compared to individuals with the IL-10 -592*C allele. The association of IL-10 A-592C gene polymorphism with coronary artery lesions of KD was examined. Both genotype and allelic frequencies were not statistically different between KD patients with and without coronary artery lesions (Table 3).
###end p 17
###begin title 18
DISCUSSION
###end title 18
###begin p 19
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 505 506 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 507 508 507 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 585 590 585 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 318 326 <span type="species:ncbi:9606">patients</span>
Kawasaki disease is an acute, inflammatory, systemic vasculitis of unknown etiology that is often complicated by coronary artery aneurysm. KD is currently thought to be an infectious disease with immunologic manifestations that occur only in genetically susceptible individuals (1). However, the genetic background of patients with KD is mostly unknown. Cytokines with polymorphic gene sequences are potential markers of disease susceptibility because their gene products are involved in KD pathogenesis (2-7). This study provides evidence for a genetic association between KD and the IL-10 gene.
###end p 19
###begin p 20
###xml 710 711 706 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 318 323 <span type="species:ncbi:9606">human</span>
The level of IL-10, one of the anti-inflammatory cytokines, is markedly elevated (as are various proinflammatory cytokines) during the acute phase of KD. IL-10 reduces the inflammatory response of monocytes/macrophages and inhibits cytokine production by Th1 cells. On the other hand, IL-10 is a potent stimulator for human B cells. The significance of increased IL-10 level observed in KD is not fully understood. It may contribute to the upregulation of humoral immune responses (increased B cell activation and hypergammaglobulinemia are observed during the acute phase of KD [20]) and to the downregulation of acute inflammation arising from increased levels of proinflammatory cytokines such as TNF-alpha(7).
###end p 20
###begin p 21
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 668 673 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 709 714 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1005 1007 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1053 1055 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1101 1106 1101 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 995 1003 <span type="species:ncbi:9606">patients</span>
###xml 1043 1051 <span type="species:ncbi:9606">patients</span>
The genetic makeup of the IL-10 promoter can determine the level of IL-10 secretion. The promoter of the IL-10 gene has been shown to be highly polymorphic. Among the identified polymorphisms in the IL-10 promoter, three linked single nucleotide polymorphisms (SNPs) (i.e., -1,082 G/A, -819 T/C, and -592 A/C) have been shown to influence the IL-10 gene expression (21). Several functional studies showed that -592*A, -819*T, and -1,082*A alleles are associated with low levels of IL-10 production (22-24). In addition, earlier reports (23, 24) found complete linkage disequilibrium between allele -819*C and allele -592*C and between allele -819*T and allele -592*A. IL-10 gene polymorphisms, especially the IL-10 A-592C polymorphism, have been implicated in associations with disease outcome. The position -592 is in an area containing putative binding sites for NF-IL-6 and STAT-1 (25). The -592*A allele has been associated with increased incidence of sepsis and mortality in critically ill patients (26) and with renal involvement in SLE patients (27). These results suggest the influence of the IL-10 A-592C polymorphism in disease progression and prognosis.
###end p 21
###begin p 22
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 76 83 76 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 671 676 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 727 735 <span type="species:ncbi:9606">patients</span>
The prevalence of IL-10 -592*A allele varies from population to population (Table 4), with the greatest rate found in Japanese (67.2%) (28), southern Chinese from Hong Kong (67%) (27), Korean (62%) (29), and British Caucasians (21%) (23, 24). In our study of Chinese healthy subjects from Taiwan, the IL-10 -592*A allele frequency was 61.0%, which is very similar to this frequency in Korean and Hong Kong Chinese but markedly different from Caucasians. The distribution of various genotypes for the IL-10 promoter polymorphic sites differ significantly between ethnic populations suggesting that this could be a useful anthropologic genetic marker. The frequency of the IL-10 -592* A allele was significantly increased in our patients with KD, suggesting that it might represent a candidate genetic marker to predict the development of KD for an individual.
###end p 22
###begin p 23
###xml 925 930 925 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 1108 1110 1108 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1181 1186 1181 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
Serum levels of an array of cytokines, including proinflammatory and anti-inflammatory cytokines, are elevated in patients with KD. Complex regulatory interactions exist to suppress ongoing inflammatory response. Regulation is often achieved via parallel secretion of antagonistic cytokines and soluble receptors. However, it is difficult to predict the net contribution of inhibitory cytokines to an inflammatory response by determination of serum levels. Furthermore, such regulation is further complicated by the ratio of cytokine to soluble receptor, such as TNF to sTNFR or IL-10 to sIL-10R, within the local environment. Therefore, we speculated that the relative lack of IL-10 compared with the elevated levels of various proinflammatory cytokines may contribute to the proinflammatory milieu in KD even though increased IL-10 level was observed during the acute phase of KD. Thus, the fact that most Asians carry the IL-10 -592*A allele (which is associated with low IL-10-secreting capacity) may partially explain why Kawasaki disease is most highly expressed in Asian populations, mainly Japanese (30). Function-related experiments and investigation to determine whether IL-10 -592*A allele is similarly associated with KD in subjects of other ethnic origin would be intriguing and worthwhile.
###end p 23
###begin p 24
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 724 729 724 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 983 988 983 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 1265 1270 1265 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 192 200 <span type="species:ncbi:9606">patients</span>
###xml 309 317 <span type="species:ncbi:9606">patients</span>
###xml 1173 1181 <span type="species:ncbi:9606">patients</span>
Of interest, a recent study conducted in a Korean population by Jin et al. (31) showed no significant difference in allele or genotype frequency for the IL-10 -592 A/C polymorphism between KD patients and control subjects but the study showed a significantly higher frequency of the IL-10 -592 C allele in KD patients with CALs. Although a relatively small sample size is a limitation of both our study and that by Jin et al., the inconsistent results may be due to environmental factors and differences in the genetic backgrounds of the study populations. Because KD appears to be a polygenic disease, and a wide number of cytokines seem to be implicated in the regulation of vasculitis. It is apparently unlikely that the IL-10 -592 polymorphism is the only gene conferring susceptibility to KD and it remains formally possible that the association may reflect linkage disequilibrium with polymorphisms in currently uncharacterized genes. As a result, although the distribution of IL-10 promoter polymorphisms is very similar in healthy controls from Taiwan and Korea, the other important immunogenetic differences in terms of disease susceptibility and severity between patients from these two populations may also explain the discordant results observed in the IL-10 gene polymorphism distribution.
###end p 24
###begin p 25
###xml 579 584 579 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 745 750 745 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
###xml 187 195 <span type="species:ncbi:9606">patients</span>
We were unable to demonstrate a role of this polymorphism in the predisposition of KD patients to the development of CALs. There may be a number of reasons for this. First, the number of patients with CALs was too small to determine a significant association. Second, this polymorphism may simply not be involved in the genetic susceptibility to CALs. Third, specific characteristics of disease pathology within KD, such as CALs formation, may be associated with specific polymorphisms in a number of genes and may represent interacting complex genetic traits. Thus, the role of IL-10 A-592C polymorphism in the development of CALs may be apparent only when it is examined in the context of the interaction of other polymorphisms in or close to IL-10 gene or located in other genes which are related to angiogenic and inflammatory processes.
###end p 25
###begin p 26
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
The present study is somewhat limited by the relatively small study population, the possibility of linkage disequilibrium with an unknown risk single nucleotide polymorphism and the lack of function-related experiments. However, our findings provide preliminary data suggesting that IL-10 -592*A allele is associated with susceptibility to KD in the Taiwanese population. To establish firmly the relationship between IL-10 promoter polymorphism and KD, further large-scale studies are required in individuals of other ethnicities.
###end p 26
###begin p 27
###xml 27 51 27 51 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">China Medical University</funding-source>
###xml 53 62 53 62 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMU95-142</award-id>
###xml 68 101 68 101 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">China Medical University Hospital</funding-source>
###xml 103 113 103 113 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DMR-91-003</award-id>
This work was supported by China Medical University (CMU95-142) and China Medical University Hospital (DMR-91-003).
###end p 27
###begin article-title 28
Kawasaki disease: infection, immunity and genetics
###end article-title 28
###begin article-title 29
###xml 91 99 <span type="species:ncbi:9606">patients</span>
The changes of interleukin-2, tumor necrosis factor, and gamma-interferon production among patients with Kawasaki disease
###end article-title 29
###begin article-title 30
###xml 92 100 <span type="species:ncbi:9606">patients</span>
Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease
###end article-title 30
###begin article-title 31
Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions
###end article-title 31
###begin article-title 32
High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease
###end article-title 32
###begin article-title 33
Evaluation of the cytokine response in Kawasaki disease
###end article-title 33
###begin article-title 34
Increased serum interleukin-10 level in Kawasaki disease
###end article-title 34
###begin article-title 35
Effects of intravenous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease
###end article-title 35
###begin article-title 36
Properties and functions of interleukin-10
###end article-title 36
###begin article-title 37
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
Two types of mouse T helper cell IV. Th2 clones secrete a factor that inhibits cytokine production by Thl clones
###end article-title 37
###begin article-title 38
IL-10 inhibits T cell proliferation and IL-2 production
###end article-title 38
###begin article-title 39
IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression
###end article-title 39
###begin article-title 40
###xml 54 59 <span type="species:ncbi:9606">human</span>
Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes
###end article-title 40
###begin article-title 41
###xml 75 80 <span type="species:ncbi:9606">human</span>
Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes
###end article-title 41
###begin article-title 42
Interleukin-10 and the interleukin-10 receptor
###end article-title 42
###begin article-title 43
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes
###end article-title 43
###begin article-title 44
Genetic influence on cytokine production and fatal meningococcal disease
###end article-title 44
###begin article-title 45
###xml 40 45 <span type="species:ncbi:9606">human</span>
Interleukin 10 secretion in relation to human IL-10 locus haplotypes
###end article-title 45
###begin article-title 46
Possible polyclonal B cell activation in mucocutaneous lymph node syndrome
###end article-title 46
###begin article-title 47
###xml 15 20 <span type="species:ncbi:9606">human</span>
Mapping of the human IL10 gene and further characterization of the 5'flanking sequence
###end article-title 47
###begin article-title 48
Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10)
###end article-title 48
###begin article-title 49
An investigation of polymorphism in the interleukin-10 gene promoter
###end article-title 49
###begin article-title 50
###xml 74 85 <span type="species:ncbi:11103">hepatitis C</span>
Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa
###end article-title 50
###begin article-title 51
###xml 17 22 <span type="species:ncbi:9606">human</span>
Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines
###end article-title 51
###begin article-title 52
###xml 102 110 <span type="species:ncbi:9606">patients</span>
Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients
###end article-title 52
###begin article-title 53
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus
###end article-title 53
###begin article-title 54
Polymorphisms of interferon-gamma gene CA-repeat and interleukin-10 promoter region (-592A/C) in Japanese type 1 diabetes
###end article-title 54
###begin article-title 55
Interleukin-10 promoter polymorphism is associated with the predisposition to the development of IgA nephropathy and focal segmental glomerulosclerosis in Korea
###end article-title 55
###begin article-title 56
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
###end article-title 56
###begin article-title 57
###xml 117 125 <span type="species:ncbi:9606">children</span>
The IL-10 (-627 A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease
###end article-title 57
###begin p 58
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Characteristics of the Kawasaki disease (KD) patients
###end p 58
###begin p 59
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Genotypes and allelic frequencies of IL-10 A-592 C promoter polymorphism in KD patients and normal control subjects
###end p 59
###begin p 60
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
*P<0.05, significant.
###end p 60
###begin p 61
IL-10, interleukin-10; KD, Kawasaki disease.
###end p 61
###begin p 62
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Genotypes and allelic frequencies of IL-10 A-592C promoter polymorphism in KD patients with and without coronary artery lesions
###end p 62
###begin p 63
IL-10, interleukin-10; KD, Kawasaki disease; CAL, coronary artery lesions.
###end p 63
###begin p 64
Allele frequencies of the interleukin-10 A-592C promoter polymorphism among Taiwanese controls and other ethnic populations
###end p 64

